4.1 Article

A comparison of preferences for two GLP-1 products – liraglutide and exenatide – for the treatment of type 2 diabetes

Journal

JOURNAL OF MEDICAL ECONOMICS
Volume 13, Issue 4, Pages 655-661

Publisher

Informa Healthcare
DOI: 10.3111/13696998.2010.529377

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available